Cantitate/Preț
Produs

Nanoarchitectonics for Smart Delivery and Drug Targeting

Autor Alina Maria Holban, Alexandru Mihai Grumezescu
en Limba Engleză Hardback – 26 iul 2016
Nanoarchitectonics for Smart Delivery and Drug Targeting is one of the first books on the market to exclusively focus on the topic of nanoarchitectonics, a rapidly developing area of nanotechnology which allows scientists to arrange nanoscale structural units, typically a group of atoms or molecules, in an intended configuration.
This book assesses novel applications of nanomaterials in the areas of smart delivery and drug targeting using nanoarchitectonics and discusses the advantages and disadvantages of each application.


  • Provides a scholarly introduction to the uses of nanoarchitectonics in drug delivery and targeting
  • Explores novel opportunities and ideas for developing and improving nanoscale drug delivery systems through the use of nanoarchitectonics, allowing scientists to see how this exciting new technology is used in practice
  • Assesses the pros and cons of each application, allowing readers to assess when it is most appropriate to use nanoarchitectonics in drug delivery
Citește tot Restrânge

Preț: 80977 lei

Preț vechi: 111778 lei
-28% Nou

Puncte Express: 1215

Preț estimativ în valută:
15497 16098$ 12873£

Carte tipărită la comandă

Livrare economică 27 ianuarie-10 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323473477
ISBN-10: 0323473474
Pagini: 970
Ilustrații: black & white illustrations
Dimensiuni: 191 x 235 x 38 mm
Greutate: 1.86 kg
Editura: ELSEVIER SCIENCE

Public țintă

Nanomaterials scientists and biomedical scientists seeking to learn more about how nanoarchitectonics can help them to create more effective drug delivery systems.

Cuprins

Part 1: Smart Delivery
1: Therapeutic Nanostructures: Application of Mechanical Engineering in Drug Delivery
2: Nanoarchitectured Biomaterials: Present Status and Future Prospects in Drug Delivery
3: Smart Nanopolysaccharides for the Delivery of Bioactives
4: Drug-Delivery Applications of Cellulose Nanofibrils
5: Nanoarchitectured Polysaccharide-Based Drug Carrier for Ocular Therapeutics
6: Current Polyesteric Systems for Advanced Drug Delivery
7: Nanobiomaterials Architectured for Improved Delivery of Antimalaria Drugs
8: Formulation of Innovative Hybrid Chitosan/TiO2- and Chitosan/SiO2-Based Drug-Delivery Systems
9: Lanthanide Ions Doped Upconversion Nanomaterials: Synthesis, Surface Engineering, and Application in Drug Delivery
10: Nanocomposite Drug Carriers
11: Lipid Nanoparticle Formulations for Enhanced Antituberculosis Therapy
12: Relevant Aspects on Peptide Delivery from Nanostructured Therapeutic Systems
13: Nanoarchitectured Mesoporous Silica-Based Drug-Delivery Systems: Toward Perfect Nanomedicine
14: Recent Advances in Self-Emulsifying Drug-Delivery Systems for Oral Delivery of Cancer Chemotherapeutics
15: Scientometric Overview in Nanobiodrugs
Part 2: Drug Targeting
16: Polymer: Lipid Hybrid Nanostructures in Cancer Drug Delivery: Successes and Limitations
17: Carbon Nanotubes: A Promising Carrier for Drug Delivery and Targeting
18: Polymeric Nanoparticles as siRNA Drug Delivery System for Cancer Therapy: The Long Road to Therapeutic Efficiency
19: Polymeric Nanobiomaterials for Tumor Targeting
20: Alginate Containing Nanoarchitectonics for Improved Cancer Therapy
21: Multifunctional Magnetic Nanostructures for Cancer Hyperthermia Therapy
22: Advances in Lasers and Nanoparticles in Treatment and Targeting of Epithelial Originated Cancers
23: Gold Nanoparticles: Their Properties and Role as Therapeutic Anticancer Agents
24: Iron Oxide Nanoparticles for Cancer Diagnosis and Therapy
25: Nanoparticle and Targeted Systems for Colon Cancer Therapy
26: Nanohybrid Stimuli-Responsive Microgels: A New Approach in Cancer Therapy
27: Multifunctional Magnetic Liposomes for Cancer Imaging and Therapeutic Applications
28: The Chemotherapeutic Potential of Gold Nanoparticles Against Human Carcinomas: A Review
29: Nanotherapeutic Platforms for Cancer Treatment: From Preclinical Development to Clinical Application
30: The Scientometric Overview in Cancer Targeting